J. Ross, E. Slodkowska, W. Symmans, L. Pusztai, P. Ravdin et al., The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine, The Oncologist, vol.14, issue.4, pp.320-68, 2009.
DOI : 10.1634/theoncologist.2008-0230

C. Hudis, Trastuzumab ??? Mechanism of Action and Use in Clinical Practice, New England Journal of Medicine, vol.357, issue.1, pp.39-51, 2007.
DOI : 10.1056/NEJMra043186

A. Musolino, N. Naldi, B. Bortesi, D. Pezzuolo, M. Capelletti et al., ???Positive Metastatic Breast Cancer, Journal of Clinical Oncology, vol.26, issue.11, pp.1789-96, 2008.
DOI : 10.1200/JCO.2007.14.8957

S. Park, Z. Jiang, E. Mortenson, L. Deng, O. Radkevich-brown et al., The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity, Cancer Cell, vol.18, issue.2, pp.160-70, 2010.
DOI : 10.1016/j.ccr.2010.06.014
URL : https://doi.org/10.1016/j.ccr.2010.06.014

R. Nahta and F. Esteva, HER2 therapy: Molecular mechanisms of trastuzumab resistance, Breast Cancer Research, vol.62, issue.Suppl, p.215, 2006.
DOI : 10.1158/1078-0432.CCR-05-0344
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1612?site=breast-cancer-research.biomedcentral.com

Y. Nagata, K. Lan, X. Zhou, M. Tan, F. Esteva et al., PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients, Cancer Cell, vol.6, issue.2, pp.117-144, 2004.
DOI : 10.1016/j.ccr.2004.06.022
URL : https://doi.org/10.1016/j.ccr.2004.06.022

T. Brodowicz, C. Wiltschke, A. Budinsky, M. Krainer, G. Steger et al., Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cellsin vitro, International Journal of Cancer, vol.7, issue.6, pp.875-884, 1997.
DOI : 10.1002/jcla.1860070107
URL : http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO;2-3/pdf

W. Köstler, B. Schwab, C. Singer, R. Neumann, E. Rücklinger et al., Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer, Clinical Cancer Research, vol.10, issue.5, pp.1618-1642, 2004.
DOI : 10.1158/1078-0432.CCR-0385-3

S. Price-schiavi, S. Jepson, P. Li, M. Arango, P. Rudland et al., Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance, International Journal of Cancer, vol.26, issue.6, pp.783-91, 2002.
DOI : 10.1016/0046-8177(95)90146-9
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.10410/pdf

A. Chen, I. Migliaccio, M. Rimawi, S. Lopez-tarruella, C. Creighton et al., Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies, Breast Cancer Research and Treatment, vol.96, issue.12, pp.583-93, 2012.
DOI : 10.1093/jnci/djh166
URL : http://europepmc.org/articles/pmc3408244?pdf=render

Y. Lu, X. Zi, Y. Zhao, D. Mascarenhas, and M. Pollak, Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin), JNCI Journal of the National Cancer Institute, vol.103, issue.2, pp.1852-1859, 2001.
DOI : 10.1016/S0092-8674(00)00112-4
URL : https://academic.oup.com/jnci/article-pdf/93/24/1852/10888865/1852.pdf

A. Mantovani, T. Schioppa, C. Porta, P. Allavena, and A. Sica, Role of tumor-associated macrophages in tumor progression and invasion, Cancer and Metastasis Reviews, vol.11, issue.3, pp.315-337, 2006.
DOI : 10.4049/jimmunol.168.7.3557

S. Ostrand-rosenberg and P. Sinha, Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer, The Journal of Immunology, vol.182, issue.8, pp.4499-506, 2009.
DOI : 10.4049/jimmunol.0802740
URL : http://www.jimmunol.org/content/jimmunol/182/8/4499.full.pdf

W. Zou, Regulatory T cells, tumour immunity and immunotherapy, Nature Reviews Immunology, vol.306, issue.4, pp.295-307, 2006.
DOI : 10.1126/science.306.5696.596

H. Waki and P. Tontonoz, Endocrine Functions of Adipose Tissue, Annual Review of Pathology: Mechanisms of Disease, vol.2, issue.1, pp.31-56, 2007.
DOI : 10.1146/annurev.pathol.2.010506.091859

S. Hefetz-sela and P. Scherer, Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention, Pharmacology & Therapeutics, vol.138, issue.2, pp.197-210, 2013.
DOI : 10.1016/j.pharmthera.2013.01.008
URL : http://europepmc.org/articles/pmc3602387?pdf=render

L. Bochet, A. Meulle, S. Imbert, B. Salles, P. Valet et al., Cancer-associated adipocytes promotes breast tumor radioresistance, Biochemical and Biophysical Research Communications, vol.411, issue.1, pp.102-108, 2011.
DOI : 10.1016/j.bbrc.2011.06.101
URL : https://hal.archives-ouvertes.fr/inserm-00617636

J. Behan, J. Yun, M. Proektor, E. Ehsanipour, A. Arutyunyan et al., Adipocytes Impair Leukemia Treatment in Mice, Cancer Research, vol.69, issue.19, pp.7867-74, 2009.
DOI : 10.1158/0008-5472.CAN-09-0800

E. Calle and R. Kaaks, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nature Reviews Cancer, vol.91, issue.8, pp.579-91, 2004.
DOI : 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T

M. Ewertz, M. Jensen, K. Gunnarsdóttir, I. Højris, E. Jakobsen et al., Effect of Obesity on Prognosis After Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.29, issue.1, pp.25-31, 2011.
DOI : 10.1200/JCO.2010.29.7614

I. Kratchmarova, D. Kalume, B. Blagoev, P. Scherer, A. Podtelejnikov et al., A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes, Molecular & Cellular Proteomics, vol.1129, issue.3, pp.213-235, 2002.
DOI : 10.1016/S0968-0004(00)01726-6

J. Houthuijzen, L. Daenen, J. Roodhart, and E. Voest, The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression, British Journal of Cancer, vol.29, issue.12, pp.1901-1907, 2012.
DOI : 10.1016/0163-7827(90)90005-6

A. Rodriguez, D. Pisani, C. Dechesne, C. Turc-carel, J. Kurzenne et al., Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse, The Journal of Experimental Medicine, vol.90, issue.9, pp.1397-405, 2005.
DOI : 10.1089/107632701753337681
URL : https://hal.archives-ouvertes.fr/hal-00304039

L. Zaragosi, G. Ailhaud, and C. Dani, Autocrine Fibroblast Growth Factor 2 Signaling Is Critical for Self-Renewal of Human Multipotent Adipose-Derived Stem Cells, Stem Cells, vol.10, issue.(suppl 1, pp.2412-2421, 2006.
DOI : 10.1128/MCB.19.1.505
URL : https://hal.archives-ouvertes.fr/hal-00304289

A. Abderrahim-ferkoune, O. Bezy, S. Astri-roques, C. Elabd, G. Ailhaud et al., Transdifferentiation of preadipose cells into smooth muscle-like cells: role of aortic carboxypeptidase-like protein, Experimental Cell Research, vol.293, issue.2, pp.219-247, 2004.
DOI : 10.1016/j.yexcr.2003.10.020
URL : https://hal.archives-ouvertes.fr/hal-00325887

J. Gong, G. Maki, and H. Klingemann, Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells, Leukemia, vol.8, pp.652-660, 1994.

B. Clémenceau, C. , N. Gallot, G. Vivien, R. Gaschet et al., Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes, Blood, vol.107, issue.12, pp.4669-77, 2006.
DOI : 10.1182/blood-2005-09-3775

C. Lequeux, C. Auxenfans, A. Mojallal, M. Sergent, and O. Damour, Optimization of a culture medium for the differentiation of preadipocytes into adipocytes in a monolayer, Biomed Mater Eng, vol.19, pp.283-91, 2009.

J. Bertout, S. Patel, and M. Simon, The impact of O2 availability on human cancer, Nature Reviews Cancer, vol.18, issue.12, pp.967-75, 2008.
DOI : 10.1172/JCI200421086
URL : http://europepmc.org/articles/pmc3140692?pdf=render

E. Maquoi, C. Munaut, A. Colige, D. Collen, and H. Lijnen, Modulation of Adipose Tissue Expression of Murine Matrix Metalloproteinases and Their Tissue Inhibitors With Obesity, Diabetes, vol.51, issue.4, pp.1093-101, 2002.
DOI : 10.2337/diabetes.51.4.1093

K. Andarawewa, E. Motrescu, M. Chenard, A. Gansmuller, I. Stoll et al., Stromelysin-3 Is a Potent Negative Regulator of Adipogenesis Participating to Cancer Cell-Adipocyte Interaction/Crosstalk at the Tumor Invasive Front, Cancer Research, vol.65, issue.23, pp.10862-71, 2005.
DOI : 10.1158/0008-5472.CAN-05-1231
URL : https://hal.archives-ouvertes.fr/hal-00187353

M. Bosma and A. Carroll, The SCID Mouse Mutant: Definition, Characterization, and Potential Uses, Annual Review of Immunology, vol.9, issue.1, pp.323-50, 1991.
DOI : 10.1146/annurev.iy.09.040191.001543

J. Tan, E. Buache, M. Chenard, N. Dali-youcef, and M. Rio, Adipocyte is a non-trivial, dynamic partner of breast cancer cells, The International Journal of Developmental Biology, vol.55, issue.7-8-9, pp.851-860, 2011.
DOI : 10.1387/ijdb.113365jt
URL : http://www.ijdb.ehu.es/web/descarga/paper/113365jt

J. Crozier, A. Moreno-aspitia, K. Ballman, A. Dueck, B. Pockaj et al., Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831, Cancer, vol.62, issue.suppl 1, pp.2447-54, 2013.
DOI : 10.3322/caac.20140

B. Kabon, A. Nagele, D. Reddy, C. Eagon, J. Fleshman et al., Obesity Decreases Perioperative Tissue Oxygenation, Anesthesiology, vol.100, issue.2, pp.274-80, 2004.
DOI : 10.1097/00000542-200402000-00015
URL : http://europepmc.org/articles/pmc1395476?pdf=render

K. Sun, C. Kusminski, and P. Scherer, Adipose tissue remodeling and obesity, Journal of Clinical Investigation, vol.121, issue.6, pp.2094-101, 2011.
DOI : 10.1172/JCI45887
URL : http://www.jci.org/articles/view/45887/files/pdf

L. De-oliveira and D. Mafra, Adipokines in obesity, Clin Chim Acta, vol.419, pp.87-94, 2013.

E. Mamessier, A. Sylvain, M. Thibult, G. Houvenaeghel, J. Jacquemier et al., Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity, Journal of Clinical Investigation, vol.121, issue.9, pp.3609-3631, 2011.
DOI : 10.1172/JCI45816DS1
URL : https://hal.archives-ouvertes.fr/hal-01765654

H. Saito, T. Osaki, and M. Ikeguchi, Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer, Gastric Cancer, vol.34, issue.1, pp.27-33, 2012.
DOI : 10.1007/s00595-004-2860-z
URL : https://link.springer.com/content/pdf/10.1007%2Fs10120-011-0059-8.pdf

Y. Zhao, R. Sun, L. You, C. Gao, and Z. Tian, Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines, Biochemical and Biophysical Research Communications, vol.300, issue.2, pp.247-52, 2003.
DOI : 10.1016/S0006-291X(02)02838-3

K. Kim, J. Kim, S. Han, J. Lim, K. Kim et al., Adiponectin Is a Negative Regulator of NK Cell Cytotoxicity, The Journal of Immunology, vol.176, issue.10, pp.5958-64, 2006.
DOI : 10.4049/jimmunol.176.10.5958
URL : http://www.jimmunol.org/content/jimmunol/176/10/5958.full.pdf

O. Delarosa, B. Sánchez-correa, S. Morgado, C. Ramírez, B. Del-río et al., Human Adipose-Derived Stem Cells Impair Natural Killer Cell Function and Exhibit Low Susceptibility to Natural Killer-Mediated Lysis, Stem Cells and Development, vol.21, issue.8, pp.1333-1376, 2012.
DOI : 10.1089/scd.2011.0139

J. Fain, A. Madan, M. Hiler, P. Cheema, and S. Bahouth, Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans, Endocrinology, vol.145, issue.5, pp.2273-82, 2004.
DOI : 10.1210/en.2003-1336

B. Dirat, L. Bochet, M. Dabek, D. Daviaud, S. Dauvillier et al., Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion, Cancer Research, vol.71, issue.7, pp.2455-65, 2011.
DOI : 10.1158/0008-5472.CAN-10-3323
URL : https://hal.archives-ouvertes.fr/inserm-00819288

B. Wajchenberg, Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome, Endocrine Reviews, vol.21, issue.6, pp.697-738, 2000.
DOI : 10.1210/edrv.21.6.0415
URL : https://academic.oup.com/edrv/article-pdf/21/6/697/8860797/edrv0697.pdf

J. Petit, M. Rietjens, E. Botteri, N. Rotmensz, F. Bertolini et al., Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study, Annals of Oncology, vol.5, issue.4, pp.1479-84, 2013.
DOI : 10.1371/journal.pone.0010240

B. Rowan, J. Gimble, M. Sheng, M. Anbalagan, R. Jones et al., Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts, PLoS ONE, vol.72, issue.2, p.89595, 2014.
DOI : 10.1371/journal.pone.0089595.s006
URL : http://doi.org/10.1371/journal.pone.0089595